Epirubicin, Porous wollastonite nanoparticles, Colorectal cancer, Antitumor efficacy, pH-responsive drug delivery
Combretastatin A4, Liposome, Doxorubicin, pH sensitive nanogel, In-situ forming hydrogel, Breast cancer